OÜ Hydroduct

Active Registry code 11954375 OÜ Tabasalu alevik Registered 11 Jun 2010
Compare

OÜ Hydroduct is a OÜ based in Tabasalu alevik, registry code 11954375, status: active. Main activity: Research and experimental development on biotechnology. Its annual report for 2025 shows revenue of €0 and 0 employees.

Revenue
0 €
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2016 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
02 0004 0006 0008 00010 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: — Industry median: 0 €20192020 Company: — Industry median: 155 €20202021 Company: — Industry median: 0 €20212022 Company: 9 000 € Industry median: 105 €20222023 Company: 0 € Industry median: 80 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €202502 0004 0006 0008 00010 0002018 Company: — Industry median: —2019 Company: — Industry median: 0 €20192020 Company: — Industry median: 155 €2021 Company: — Industry median: 0 €20212022 Company: 9 000 € Industry median: 105 €2023 Company: 0 € Industry median: 80 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 0 € · industry median 0 € · above 40% of the industry
-1 00001 0002 0003 0004 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 0 € Industry median: 2 €20192020 Company: -603 € Industry median: 32 €20202021 Company: — Industry median: 1 €20212022 Company: 3 972 € Industry median: 0 €20222023 Company: 0 € Industry median: 0 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €2025-1 00001 0002 0003 0004 0002018 Company: — Industry median: —2019 Company: 0 € Industry median: 2 €20192020 Company: -603 € Industry median: 32 €2021 Company: — Industry median: 1 €20212022 Company: 3 972 € Industry median: 0 €2023 Company: 0 € Industry median: 0 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2022: 44.1 % · industry median 17.7 % · above 69% of the industry
010203040502016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: — Industry median: 12.7 %20192020 Company: — Industry median: 23.8 %20202021 Company: — Industry median: 25.1 %20212022 Company: 44.1 % Industry median: 17.7 %20222023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %20242025 Company: — Industry median: 13.5 %2025010203040502018 Company: — Industry median: —2019 Company: — Industry median: 12.7 %20192020 Company: — Industry median: 23.8 %2021 Company: — Industry median: 25.1 %20212022 Company: 44.1 % Industry median: 17.7 %2023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %2025 Company: — Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 6 802 € · +0.0% vs 2024
02 0004 0006 0008 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 3 433 €20192020 Company: 2 830 €20202021 Company: 2 830 €20212022 Company: 6 802 €20222023 Company: 6 802 €20232024 Company: 6 802 €20242025 Company: 6 802 €202502 0004 0006 0008 0002018 Company: —2019 Company: 3 433 €20192020 Company: 2 830 €2021 Company: 2 830 €20212022 Company: 6 802 €2023 Company: 6 802 €20232024 Company: 6 802 €2025 Company: 6 802 €2025
Equity, € 2025: 6 802 € · +0.0% vs 2024
02 0004 0006 0008 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 3 433 €20192020 Company: 2 830 €20202021 Company: 2 830 €20212022 Company: 6 802 €20222023 Company: 6 802 €20232024 Company: 6 802 €20242025 Company: 6 802 €202502 0004 0006 0008 0002018 Company: —2019 Company: 3 433 €20192020 Company: 2 830 €2021 Company: 2 830 €20212022 Company: 6 802 €2023 Company: 6 802 €20232024 Company: 6 802 €2025 Company: 6 802 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: 120182019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02018 Company: 0 Industry median: 12019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 0 0 6 802 6 802 0
2024 0 0 — 6 802 6 802 0
2023 0 0 — 6 802 6 802 0
2022 9 000 3 972 — 6 802 6 802 0
2021 — — — 2 830 2 830 0
2020 — -603 — 2 830 2 830 0
2019 — 0 — 3 433 3 433 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0
2015 — — — — — 0
2014 — — — — — 0
2013 — — — — — 0
2012 — — — — — 0
2011 — — — — — 0
2010 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
0.0 %
Net profit / equity
Return on assets (ROA)
0.0 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 1 Jul 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 29 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 26 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 5 Jul 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 1 Jul 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 19 May 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main
Rulings
Number, date Title Deadline State Document
Ä 20052465 / 13
15 Jul 2024
Entry refused In force
2 Aug 2024
PDF
Ä 20052465 / M7
1 Jul 2024
Procedural ruling 11 Jul 2024 In force
1 Jul 2024
PDF
Ä 20052465 / 12
2 Sep 2023
Amendment entry In force
2 Sep 2023
PDF
Ä 20052465 / 11
30 Aug 2022
Amendment entry In force
30 Aug 2022
PDF
Ä 20052465 / M6
29 Aug 2022
Ruling to eliminate deficiencies 8 Sep 2022 Deficiencies eliminated
30 Aug 2022
PDF
Ä 20052465 / 10
12 Oct 2020
Amendment entry In force
12 Oct 2020
PDF
Ä 20052465 / 9
17 Jan 2018
Amendment entry In force
17 Jan 2018
PDF
Ä 20052465 / 8
29 Dec 2017
Amendment entry In force
29 Dec 2017
PDF
Ä 20052465 / M5
28 Dec 2017
Ruling to eliminate deficiencies 7 Jan 2018 Deficiencies eliminated
29 Dec 2017
PDF
Ä 20052465 / M4
27 Dec 2017
Ruling to eliminate deficiencies 16 Jan 2018 Deficiencies eliminated
29 Dec 2017
PDF
Ä 20052465 / 7
23 Dec 2017
Amendment entry In force
23 Dec 2017
PDF
Ä 20052465 / 6
1 Dec 2017
Amendment entry In force
1 Dec 2017
PDF
Ä 20052465 / 5
5 Mar 2012
Amendment entry In force
5 Mar 2012
PDF
Ä 20052465 / M3
1 Mar 2012
Ruling to eliminate deficiencies 1 Apr 2012 In force
1 Mar 2012
PDF
Ä 20052465 / 4
16 Sep 2011
Amendment entry In force
16 Sep 2011
PDF
Ä 20052465 / M2
17 Aug 2011
Ruling to eliminate deficiencies 17 Sep 2011 In force
17 Aug 2011
PDF
Ä 20052465 / 3
29 Jun 2011
Amendment entry In force
29 Jun 2011
PDF
Ä 20052465 / M1
22 Jun 2011
Ruling to eliminate deficiencies In force
22 Jun 2011
PDF
Ä 20052465 / 2
9 Aug 2010
Amendment entry In force
9 Aug 2010
PDF
Ä 20052465
11 Jun 2010
First entry In force
11 Jun 2010
PDF

Sources: e-Äriregister and EMTA. Data updated 27 Oct 2026. Open at the source ↗ · Report an error in the data